(A) An amino acid sequence alignment of CypA from diverse species. Similar amino acids are indicated in boxed, bold capital letters while differences are lowercase. Species are arranged from top to …
(A) Western blot demonstrating knockdown of human CypA in Huh7.5-shRNA CypA cells relative to the parental Huh7.5 cells and those expressing an shRNA against an irrelevant target (Huh7.5-shRNA …
Bicistronic constructs expressing the CypA orthologs of interest followed by an IRES-regulated eGFP-ubiquitin-neomycin fusion protein were used to transduce Huh7.5-shRNA CypA cells. Transduction …
(A) Schematic depicting the humanized murine CypA and murinized human CypA constructs tested. (B) Modeled structure of human CypA (PDB 1CWA) with the six residues differing between murine and human …
Bicistronic constructs expressing the CypA mutants shown in Figure 2A followed by an IRES-regulated eGFP-ubiquitin-neomycin fusion protein were used to transduce Huh7.5-shRNA CypA cells. …
Cell lysates were collected from the transduced Huh7.5-shRNA CypA cells shown in Figure 2 and Figure 2—figure supplement 1 and expression determined by western blot (please see Supplementary file 1) …
(A) Schematic of the additional humanized mouse CypA mutants tested. (B) Huh7.5-shRNA CypA cells were transduced with the mutants shown in (A) and infected with Jc1-Gluc at MOI = 0.1. Supernatants …
Bicistronic constructs expressing the CypA mutants shown in Figure 3A followed by an IRES-regulated eGFP-ubiquitin-neomycin fusion protein were used to transduce Huh7.5-shRNA CypA cells. …
Huh7.5-shRNA CypA cells non-transduced or transduced with a 3x-FLAG-tagged human CypA, mouse CypA (expressing eGFP), or both (A) were infected with Jc1-Gluc (MOI = 0.1). (B) At five dpi, cells were …
Cells were transduced with either mouse CypA-IRES-eGFP alone, human CypA-3x FLAG, both human and mouse, or nothing for the competition experiment shown in Figure 4. Transduction efficiency of both …
(A) Schematic of experimental workflow. SN, supernatant; Gluc, Gaussia luciferase. Image created with BioRender. (B) Huh7.5-shRNA CypA cells non-transduced or transduced with human, mouse or triply …
(A) Schematic of the engineered murine hepatoma cell line, Clone 8 + murine ApoE (mApoE) derived from Hep56.1D cells. (B) SEC14L2 expression verified by western blot. Mouse anti-human SEC14L2 shown …
(A) Clone 8 + ApoE cells were transduced with mouse, human, triply murinized human, or triply humanized mouse CypA in bicistronic lentiviral constructs expressing eGFP. Transduction efficiency …
Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
---|---|---|---|---|
antibody | mouse monoclonal anti-B-actin | Cell Signaling Technology | Cell Signaling Technology:3700 | used at 1:1000 for western blot |
antibody | rabbit polyclonal anti-CypA | Cell Signaling Technology | Cell Signaling Technology:2175S | used at 1:1000 for western blot |
antibody | rabbit monoclonal anti-GFP (D5.1) XP | Cell Signaling Technology | Cell Signaling Technology:2956S | used at 1:1000 for western blot |
antibody | goat anti-mouse IgG (H + L) secondary, Dylight 680 | Thermo Fisher Scientific | Thermo Fisher Scientific:35568 | used at 1:10,000 for western blot |
antibody | goat anti-mouse IgG (H + L) secondary, Dylight 800 | Thermo Fisher Scientific | Thermo Fisher Scientific:SA535521 | used at 1:10,000 for western blot |
antibody | goat anti-rabbit IgG (H + L) cross-adsorbed secondary, Alexa 700 | Invitrogen | Invitrogen:A-21038 | used at 1:250 for flow cytometry |
antibody | goat anti-mouse IgG (H + L) cross-adsorbed secondary, Alexa 647 | Invitrogen | Invitrogen:A-21235 | used at 1:250 for flow cytometry |
antibody | rabbit anti-β actin | Cell Signaling Technology | Cell Signaling Technology:4970S | used at 1:2000 for western blot |
antibody | mouse monoclonal anti-human CypA | AbCam | AbCam:58144 | used at 1:1000 (from 1 mg/mL stock) for western blot |
antibody | monoclonal, human CD81 conjugated to PE | BD Biosciences, Inc. | BD Biosciences, Inc:BDB555676 | used at 1:200 for flow cytometry |
antibody | mouse monoclonal anti-human SEC14L2 | LifeSpan BioSciences, Inc. | LifeSpan BioSciences, Inc:LS-B11733 | used at 1:1000 for western blot |
antibody | rabbit monoclonal anti-FLAG | Cell Signaling Technology | Cell Signaling Technology:14793S | used at 1:1500 for flow cytometry |
antibody | mouse monoclonal 9E10 | Charles Rice (Rockefeller University) | antibody against HCV NS5A; published in Lindenbach et al., 2005 | |
cell line (Homo sapiens) | Huh7.5.1 | Frank Chisari (The Scripps Research Institute) | RRID:CVCL_E049 | Human hepatoma cell line |
cell line (Mus musculus) | Hep56.1D | CLS Cell Lines Service GmbH (Eppelheim, Germany) | RRID:CVCL_5769 | Murine hepatoma cell line |
cell line (Mus musculus) | Clone 8 | this paper | Please see methods section in manuscript for detailed information concerning the generation of this line from Hep56.1D cells and the plasmids used | |
cell line (Homo sapiens) | 293T | Charles Rice (Rockefeller University) | RRID:CVCL_0063 | Human embryonic kidney cell line |
cell line (Homo sapiens) | Huh7.5 | Charles Rice (Rockefeller University) | RRID:CVCL_7927 | Human hepatoma cell line |
cell line (Homo sapiens) | Huh7.5-shRNA-irrel | von Hahn et al., 2012 | Human hepatoma cell line Huh7.5 expressing an shRNA against an irrelevant target | |
cell line (Homo sapiens) | Huh7.5-shRNA-CypA | von Hahn et al., 2012 | Human hepatoma cell line Huh7.5 expressing an shRNA against human CypA | |
cell line (Homo sapiens) | Huh7 | Charles Rice (Rockefeller University) | RRID:CVCL_0336 | Human hepatoma cell line |
commercial assay or kit | Gibson Assembly kit | New England Biolabs | NEB:E5510s | |
commercial assay or kit | In-Fusion HD Cloning | Clontech | Clontech:639647 | |
commercial assay or kit | QuikChange XL Site-Directed Mutagenesis kit | Agilent | Agilent:200517 | |
commercial assay or kit | QuikChange Multi Site-Directed Mutagenesis kit | Agilent | Agilent:200514 | |
commercial assay or kit | Luc-Pair Renilla Luciferase HS Assay Kit | GeneCopoeia | GeneCopoeia:LF012 | |
commercial assay or kit | T7 RiboMAX Express Large Scale RNA Production kit | Promega | Promega:PRP1320 | |
recombinant DNA reagent (plasmid) | Jc1(p7nsGluc2a) | Marukian et al., 2008 | ||
recombinant DNA reagent (plasmid) | pWPI-human CypA-IRES-GUN | von Hahn et al., 2012 | plasmid expressing human CypA open reading frame followed by IRES-regulated green fluorescent protein (GFP)-ubiquitin-neomycin (GUN) fusion protein | |
recombinant DNA reagent (plasmid) | pWPI-orangutan CypA-IRES-GUN | this paper | plasmid expressing orangutan CypA open reading frame followed by IRES-GUN | |
recombinant DNA reagent (plasmid) | pWPI-tree shrew CypA-IRES-GUN | this paper | plasmid expressing tree shrew CypA open reading frame followed by IRES-GUN | |
recombinant DNA reagent (plasmid) | pWPI-squirrel monkey CypA-IRES-GUN | this paper | plasmid expressing squirrel monkey CypA open reading frame followed by IRES-GUN | |
recombinant DNA reagent (plasmid) | pWPI-mouse CypA-IRES-GUN | this paper | plasmid expressing pigtailed macaque TRIM-CypA open reading frame followed by IRES-GUN | |
recombinant DNA reagent (plasmid) | pWPI-humanized mouse CypA-IRES-GUN mutants | this paper | The six amino acid residues that differ between human and mouse CypA were changed one at a time or in varying combinations in mouse CypA to make it ‘humanized.’ Please see Materials and methods section for the generation of all these plasmids | |
recombinant DNA reagent (plasmid) | pWPI-murinized human CypA-IRES-GUN mutants | this paper | The six amino acid residues that differ between human and mouse CypA were changed one at a time or in varying combinations in human CypA to make it ‘murinized.’ Please see Materials and methods section for the generation of all these plasmids | |
recombinant DNA reagent (plasmid) | pWPI-pigtailed macaque TRIM-CypA-IRES-GUN | this paper | ||
recombinant DNA reagent (plasmid) | pLVX-IRES-puro | Clontech | Clontech:632183 | |
sequence-based reagent | all primers beginning with PU-O- | Integrated DNA Technologies | please see Table 1 in the Materials and methods section for all primer sequences and their use | |
software, algorithm | GraphPad Prism | GraphPad Software, Inc | Version 6.0e | |
software, algorithm | FlowJo | FlowJo, LLC | Version 10.4.2 | |
software, algorithm | MacVector | MacVector, Inc | Version 12.7.4 |
Primer ID | Nucleotide sequence (5’−3’) |
---|---|
PU-O-3432 | TGCAGCCCGTAGTTTACTAGTTTATTCGAGTTGTCCACAGTCAG |
PU-O-3428 | ACCTGCAGGCGCGCCGGATCCATGGTCAACCCTACCGTGTTCTTGGACATT |
PU-O-3853 | TTCTTCGACATTACGGTCGACGGCGAGCCC |
PU-O-3854 | GGGCTCGCCGTCGACCGTAATGTCGAAGAA |
PU-O-3855 | TTCGACATTGCCGCCGACGGCGAGCCC |
PU-O-3856 | GGGCTCGCCGTCGGCGGCAATGTCGAA |
PU-O-3857 | ATTGCCGTCGACGACGAGCCCTTGGGC |
PU-O-3858 | GCCCAAGGGCTCGTCGTCGACGGCAAT |
PU-O-3859 | TATAAGGGTTCCTCCTTTCACAGAATTATTCC |
PU-O-3860 | GGAATAATTCTGTGAAAGGAGGAACCCTTATA |
PU-O-3861 | GGCACTGGTGGCAGGTCCATCTATGGG |
PU-O-3862 | CCCATAGATGGACCTGCCACCAGTGCC |
PU-O-3863 | AAGATCACCATTTCCGACTGTGGACAACTC |
PU-O-3864 | GAGTTGTCCACAGTCGGAAATGGTGATCTT |
PU-O-3871 | TTCTTCGACATCGCCGCCGATGACGAG |
PU-O-3872 | CTCGTCATCGGCGGCGATGTCGAAGAA |
PU-O-3873 | TTCGACATCACGGTCGATGACGAGCCC |
PU-O-3874 | GGGCTCGTCATCGACCGTGATGTCGAA |
PU-O-3875 | ATCACGGCCGATGGCGAGCCCTTGGGC |
PU-O-3876 | GCCCAAGGGCTCGCCATCGGCCGTGAT |
PU-O-3877 | TATAAGGGTTCCTGCTTTCACAGAATTATTCC |
PU-O-3878 | GGAATAATTCTGTGAAAGCAGGAACCCTTATA |
PU-O-3879 | GGCACTGGCGGCAAGTCCATCTACGGAGAG |
PU-O-3880 | CTCTCCGTAGATGGACTTGCCGCCAGTGCC |
PU-O-3881 | AAGATCACCATTGCTGACTGTGGACAG |
PU-O-3882 | CTGTCCACAGTCAGCAATGGTGATCTT |
PU-O-1755 | ATGAGCGGCAGAGTCGGCGATCTGA |
PU-O-1756 | TTATTTCGGGGTGCCTGCCCCCAGC |
PU-O-1943 | TATTTCCGGTGAATTCCTCGAGATGAGCGGCAGAG |
PU-O-1944 | GGGAGGGAGAGGGGCGGGATCCTTATTTCGGGGTG |
PU-O-3851 | CTTGCATGCCTGCAGGTCGACATGGTCAACCCCACC |
PU-O-3852 | CGGCCAGTGAATTCGAGCTCGGTACCTTATTCGAGTTGTCC |
PU-O-4211 | CGGCCAGTGAATTCGAGCTCGGTACCTTAGAGCTGTCCACAGTC |
PU-O-3424 | ACCTGCAGGCGCGCCGGATCCATGGTCAACCCCACCGTGTT |
PU-O-3429 | TGCAGCCCGTAGTTTACTAGTTTAGAGCTGTCCACAGTCGGAAA |
PU-O-3432 | TGCAGCCCGTAGTTTACTAGTTTATTCGAGTTGTCCACAGTCAG |
Detection of CypA expression by western blotting.
All the constructs utilized in this paper were analyzed by western blot across two membranes. Shown here are the membranes after exposure to different combinations of antibodies, with the column on the left all images of one membrane and the column on the right images of the second. Whether the bands observed in a given set of membranes originated from the goat, mouse or both secondary antibodies is delineated at the left of each row. The proteins represented by the bands are also labeled, with ‘(M)’ and ‘(R)’ indicating signal from anti-mouse or anti-rabbit secondary, respectively. The blots shown in (A) were incubated with the following primary antibodies: rabbit anti-GFP (1:1000, Cell Signaling Technologies #2956S), mouse anti-β-actin (1:1000, Cell Signaling Technologies, #3700), and rabbit anti-CypA (1:1000, Cell Signaling Technologies #2175S). These blots were stripped and re-probed in (B) with the following primary antibodies: rabbit anti-GFP (1:1000, Cell Signaling Technolgoies #2956S), rabbit anti-β-actin (1:1000, 4970S), and mouse anti-CypA (1:1000, AbCam, Ab58144). Note that for more accurate quantification, the β-actin and CypA antibodies used in (B) were raised in different host species from those in (A) so that the residual signal left on the membrane from the first probing could be distinguished. For (A), the signal from the anti-rabbit secondary was used to quantify the CypA bands and that from the anti-mouse secondary for β-actin. For (B), the signal from the anti-mouse secondary was used to quantify the CypA bands and that from the anti-rabbit secondary for β-actin. The quantifications for these bands are shown in the respective Figure Supplements for the experiments where each construct was used. The source of the protein lysate run in each lane and size of the expected bands is listed in (C) in accordance with the numbers listed at the top of each membrane.
Protein sequence similarity and identity matrices of PI4KA from select species.